AVTR logo

AVANTOR INC

AVTRNYSE
πŸ† #731 by market capEarnings Oct 28 Β· PreUS Equity
β€”β€”
Quote unavailable
πŸ””
Track AVTR
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$11.69B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
-1.6%
Declining
πŸ“ŠGross Margin
31.8%
Moderate
πŸ’΅FCF Margin
6.9%
Moderate
βš–οΈP/S Ratio
1.8x
Cheap
Otter Score
72
Strong
No chart data available for AVTR.

Trading Snapshot

Day Range
β€”
52-Week Range
$7.27 – $17.45
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
676.4M
Next Earnings
2026-10-28

Fundamentals Snapshot

Annual Revenue
$6.55B
Last Q Revenue
$1.69B
P/E Ratio
β€”
P/S Ratio
1.8x
EPS (TTM)
$-0.85
Dividend Yield
β€”
Dilution (1yr)
βˆ’0.5%
AVTR logo

AVANTOR INC

AVTR
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$6.6Bβ–Ό βˆ’3.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
32.7%β–Ό βˆ’2.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$246Mβ–Ό βˆ’122.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$495Mβ–Ό βˆ’28.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
679.3Mβ–Ό βˆ’0.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$3.6Bβ–² +$213M YoY
StockOtter Β· stockotter.space

About AVANTOR INC

Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
72/100

Analyst Ratings

β“˜
Consensus
Hold
24 analysts
Strong Buy3
Buy4
Hold16
Sell1
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.